These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28867703)

  • 1. Patient Preference for Aggressive Medication Therapies with Potentially Stronger Adverse Drug Reactions Revealed Using a Scenario-based Survey.
    Iihara N; Ohara E; Nishio T; Muguruma H; Matsuoka E; Houchi H; Kirino Y
    Yakugaku Zasshi; 2017; 137(9):1161-1167. PubMed ID: 28867703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of endurance for adverse drug reactions on the preference for aggressive treatments in cancer patients.
    Iihara N; Nishio T; Goda T; Anzai H; Kagawa M; Houchi H; Kirino Y
    Support Care Cancer; 2015 Apr; 23(4):1091-7. PubMed ID: 25294657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
    Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
    Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the Increased Probability of Detecting Adverse Drug Reactions Based on Bayes' Theorem: Evaluation of the Usefulness of Information on the Onset Timing of Adverse Drug Reactions.
    Oshima S; Enjuji T; Negishi A; Akimoto H; Ohara K; Okita M; Numajiri S; Inoue N; Ohshima S; Terao A; Kobayashi D
    Biol Pharm Bull; 2017 Sep; 40(9):1389-1398. PubMed ID: 28579595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-rater reliability of the assessment of adverse drug reactions in the hospitalised elderly.
    Tangiisuran B; Auyeung V; Cheek L; Rajkumar C; Davies G
    J Nutr Health Aging; 2013; 17(8):700-5. PubMed ID: 24097025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardized patients' preferences for pharmacist interactive communication style: A mixed method approach.
    Guirguis LM; Nusair MB
    J Am Pharm Assoc (2003); 2016; 56(2):123-8. PubMed ID: 27000161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey.
    Mouton JP; Mehta U; Parrish AG; Wilson DP; Stewart A; Njuguna CW; Kramer N; Maartens G; Blockman M; Cohen K
    Br J Clin Pharmacol; 2015 Oct; 80(4):818-26. PubMed ID: 25475751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving medication safety and diabetes management in Hong Kong: a multidisciplinary approach.
    Chung AY; Anand S; Wong IC; Tan KC; Wong CF; Chui WC; Chan EW
    Hong Kong Med J; 2017 Apr; 23(2):158-67. PubMed ID: 28302923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician-patient and pharmacist-patient communication: geriatrics' perceptions and opinions.
    Keshishian F; Colodny N; Boone RT
    Patient Educ Couns; 2008 May; 71(2):265-84. PubMed ID: 18308499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Views of British community pharmacists on direct patient reporting of adverse drug reactions (ADRs).
    Krska J
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1130-3. PubMed ID: 22729956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing community pharmacists' likelihood to ask medication monitoring questions: A factorial survey.
    Witry MJ; Doucette WR
    Res Social Adm Pharm; 2015; 11(5):639-50. PubMed ID: 25573019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot testing of checklists to discern adverse drug reactions and adverse drug events.
    Chen AM; Kiersma ME; Shepler BM; Murawski MM
    J Am Pharm Assoc (2003); 2013; 53(1):61-9. PubMed ID: 23636158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand.
    Patsuree A; Krska J; Jarernsiripornkul N
    Expert Opin Drug Saf; 2016; 15(3):287-95. PubMed ID: 26750422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADVERSE DRUG REACTIONS: FACTORS AND ROLE OF PHARMACIST IN THEIR PREVENTION.
    Bushra R; Baloch SA; Jabeen A; Bano N; Aslam N
    J Ayub Med Coll Abbottabad; 2015; 27(3):702-6. PubMed ID: 26721044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a pilot medication therapy management project within the North Carolina State Health Plan.
    Christensen DB; Roth M; Trygstad T; Byrd J
    J Am Pharm Assoc (2003); 2007; 47(4):471-83. PubMed ID: 17616493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferences for pharmacist counselling in patients with breast cancer: a discrete choice experiment.
    Kawaguchi T; Azuma K; Yamaguchi T; Iwase S; Matsunaga T; Yamada K; Miyamatsu H; Takeuchi H; Kohno N; Akashi T; Unezaki S
    Biol Pharm Bull; 2014; 37(11):1795-802. PubMed ID: 25212541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring patient expectations for pharmacist-provided literacy-sensitive communication.
    Collum JL; Marcy TR; Stevens EL; Burns CF; Miller MJ
    Res Social Adm Pharm; 2013; 9(5):626-32. PubMed ID: 22835713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.